Physician profile
Alan Mobley
NPI 1871541466
$2,728.01
in general payments reported to CMS, 2019-2025
13 companies · $553 in 2025
The $553 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $293 · 2020: $669 · 2021: $328 · 2022: $269 · 2023: $407 · 2024: $209 · 2025: $553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,168.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,571.92 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $236.63 | 2022-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $201.57 | 2021-2023 | Xarelto |
| Pfizer INC. | $174.37 | 2020-2023 | |
| Novartis Pharmaceuticals Corporation | $154.11 | 2019-2024 | |
| Esperion Therapeutics, INC. | $136.60 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $128.50 | 2019-2021 | |
| Vivaquant INC, Dba Rhythm Express | $34.93 | 2024 | Rhythm Express |
| Irhythm Technologies, INC. | $26.91 | 2024 | Zio Monitor, Zio Xt Patch |
| Medtronic, INC. | $23.24 | 2022 | |
| Boston Scientific Corporation | $13.47 | 2024 | Lithovue |
| Sanofi-Aventis U.S. LLC | $13.00 | 2022 | |
| Azurity Pharmaceuticals, INC. | $12.76 | 2023 | Edarbyclor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Mobley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.